Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years

被引:11
作者
Moller, Burkhard [1 ]
Aletaha, Daniel [2 ]
Andor, Michael [3 ]
Atkinson, Andrew [1 ,4 ]
Aubry-Rozier, Berengere [5 ]
Brulhart, Laure [6 ]
Dan, Diana [5 ]
Finckh, Axel [7 ]
Grobety, Veronique [8 ]
Mandl, Peter [2 ]
Micheroli, Raphael [9 ]
Nissen, Michael John [7 ]
Nydegger, Alexander M. [10 ]
Scherer, Almut [4 ]
Tamborrini, Giorgio [11 ]
Ziswiler, Hans-Rudolf [12 ]
Zufferey, Pascal [5 ]
机构
[1] Univ Hosp Bern, Inselspital, Rheumatol Immunol & Allergy, Bern, Switzerland
[2] Med Univ Vienna, Med Dept 3, Rheumatol, Vienna, Austria
[3] Prodorso, Zurich, Switzerland
[4] SCQM Stat Grp, Zurich, Switzerland
[5] Lausanne Univ Hosp, Rheumatol, Lausanne, Switzerland
[6] Hop Neuchatelois, Rheumatol, La Chaux De Fonds, Switzerland
[7] Univ Hosp Geneva, Rheumatol, Geneva, Switzerland
[8] Victoriapl Ctr Rheumatol, Bern, Switzerland
[9] Univ Hosp Zurich, Rheumatol, Zurich, Switzerland
[10] Klin Schloss Mammern, Rheumatol & Rehabil, Mammern, Switzerland
[11] Basel Inst Locomotor Syst Ultrasound, Basel, Switzerland
[12] Osteorheuma, Bern, Switzerland
关键词
rheumatoid arthritis; hand; synovium; ultrasonography; biological therapies; MODIFYING ANTIRHEUMATIC DRUGS; CLINICAL-DISEASE ACTIVITY; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; RADIOGRAPHIC PROGRESSION; PLUS METHOTREXATE; PROVISIONAL DEFINITION; JOINT DAMAGE; REMISSION; RECOMMENDATIONS;
D O I
10.1093/rheumatology/kez460
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To evaluate grey scale US (GSUS) and power Doppler US synovitis (PDUS), separately or in combination (CombUS), to predict joint damage progression in RA. Methods. In this cohort study nested in the Swiss RA register, all patients with sequential hand radiographs at their first US assessment were included. We analysed the summations of semi-quantitative GSUS, PDUS and CombUS assessments of both wrists and 16 finger joints (maximum 54 points) at their upper limit of normal, their 50th, 75th or 87.5th percentiles for the progression of joint damage (Delta Xray). We adjusted for clinical disease activity measures at baseline, the use of biological DMARDs and other confounders. Results. After a median of 35 months, 69 of 250 patients with CombUS (28%), 73 of 259 patients with PDUS (28%) and 75 of 287 patients with available GSUS data (26%) demonstrated joint damage progression. PDUS beyond upper limit of normal (1/54), GSUS and CombUS each at their 50th (9/54 and 10/54) and their 75th percentiles (14/54 and 15/54) were significantly associated with Delta Xray in crude and adjusted models. In subgroup analyses, GSUS beyond 14/54 and CombUS higher than 15/54 remained significantly associated with Delta Xray in patients on biological DMARDs, while clinical disease activity measures had no significant prognostic power in this subgroup. Conclusion. Higher levels of GSUS and CombUS are associated with the development of erosions. GSUS appears to be an essential component of synovitis assessment and an independent predictor of joint damage progression in patients on biological DMARDs.
引用
收藏
页码:1556 / 1565
页数:10
相关论文
共 47 条
  • [21] Power doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity
    Foltz, Violaine
    Gandjbakhch, Frederique
    Etchepare, Fabien
    Rosenberg, Carole
    Tanguy, Marie Laure
    Rozenberg, Sylvie
    Bourgeois, Pierre
    Fautrel, Bruno
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (01): : 67 - 76
  • [22] Fransen J, 2006, CLIN EXP RHEUMATOL, V24, pS29
  • [23] The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study
    Kyburz, Diego
    Gabay, Cem
    Michel, Beat A.
    Finckh, Axel
    [J]. RHEUMATOLOGY, 2011, 50 (06) : 1106 - 1110
  • [24] Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate -: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes
    Landewe, Robert
    van der Heijde, Desiree
    Klareskog, Lars
    van Vollenhoven, Ronald
    Fatenejad, Saeed
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (10): : 3119 - 3125
  • [25] Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort
    Lillegraven, Siri
    Prince, Femke H. M.
    Shadick, Nancy A.
    Bykerk, Vivian P.
    Lu, Bing
    Frits, Michelle L.
    Iannaccone, Christine K.
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Weinblatt, Michael E.
    Solomon, Daniel H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (05) : 681 - 686
  • [26] Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis
    Mangnus, Lukas
    van Steenbergen, Hanna W.
    Lindqvist, Elisabet
    Brouwer, Elisabeth
    Reijnierse, Monique
    Huizinga, Tom W. J.
    Gregersen, Peter K.
    Berglin, Ewa
    Rantapaa-Dahlqvist, Solbritt
    van der Heijde, Desiree
    van der Helm-van Mil, Annette H. M.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [27] The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself?
    McQueen, Fiona
    Naredo, Esperanza
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) : 241 - 244
  • [28] Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study
    Moeller, Burkhard
    Scherer, Almut
    Foerger, Frauke
    Villiger, Peter M.
    Finckh, Axel
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) : 691 - 696
  • [29] Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission
    Molenaar, ETH
    Voskuyl, AE
    Dinant, HJ
    Bezemer, PD
    Boers, M
    Dijkmans, BAC
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (01): : 36 - 42
  • [30] Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis The IMAGINE-RA Randomized Clinical Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo
    Hetland, Merete Lund
    Ornbjerg, Lykke Midtboll
    Glinatsi, Daniel
    Moller, Jakob
    Boesen, Mikael
    Christensen, Robin
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Hendricks, Oliver
    Asmussen, Karsten
    Kowalski, Marcin
    Lindegaard, Hanne
    Nielsen, Sabrina Mai
    Bliddal, Henning
    Krogh, Niels Steen
    Ellingsen, Torkell
    Nielsen, Agnete H.
    Balding, Lone
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Ostergaard, Mikkel
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (05): : 461 - 472